Evaluation of Aminoglycoside Dosing Regimens Adjusted for Renal Function and In Vitro Susceptibility Test Interpretive Criteria for Enterobacterales and Pseudomonas aeruginosa
Sujata M Bhavnani, Jeffrey P Hammel, Nikolas J Onufrak, Jason M Pogue, Ronald N Jones, Helio S Sader, George L Drusano, John S Bradley, David R Andes, William A Craig, Paul G Ambrose · 2025
Read Evaluation of Aminoglycoside Dosing Regimens Adjusted for Renal Function and In Vitro Susceptibility Test Interpretive Criteria for Enterobacterales and Pseudomonas aeruginosa by Sujata M Bhavnani, Jeffrey P Hammel, Nikolas J Onufrak, Jason M Pogue, Ronald N Jones, Helio S Sader, George L Drusano, John S Bradley, David R Andes, William A Craig, Paul G Ambrose (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12651555.txt.
Description
BackgroundAppropriate in vitro susceptibility testing interpretive criteria (STIC) are crucial to ensure optimal patient care. Pharmacometric analyses for aminoglycosides were undertaken to provide recommendations for dosing regimens adjusted for renal function and to support the original 2019 and 2023 reassessments of STIC for Enterobacterales and Pseudomonas aeruginosa.
Catalog record
| CREATOR | Sujata M Bhavnani, Jeffrey P Hammel, Nikolas J Onufrak, Jason M Pogue, Ronald N Jones, Helio S Sader, George L Drusano, John S Bradley, David R Andes, William A Craig, Paul G Ambrose |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 59 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |